B cell lymphoma vaccine - Large Scale Biology Corporation
Latest Information Update: 20 Feb 2008
At a glance
- Originator Large Scale Biology Corporation (CEASED); Stanford University School of Medicine
- Developer Stanford University School of Medicine
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma